NobleStitch Patent Foramen Ovales Closure for Recurrent Strokes in a Patient with COVID-19 on Extracorporeal Membrane Oxygenation

Stout, Perry A.; Tribble, Matt; Richvalsky, Tanya; Youn, Cindy; Winston, Brion; Shapeton, Alexander D.; Tabrizi, Nika Samadzadeh

doi:10.1053/j.jvca.2022.10.014

Cited by 2 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are several important anatomical features to consider when performing PFO closure using the NobleStitch EL device. A recent retrospective observational study showed that a PFO width of >5 mm and larger (grade 2–3) preprocedural right to left shunts were associated with a lower likelihood of successful PFO closure with 1 suture ( 37 ). Utilization of more than one stitch for complete closure in these cases may be necessary.…”

Section: Introductionmentioning

confidence: 99%

Transcatheter PFO closure for cryptogenic stroke: current approaches and future considerations

Eltelbany,

Gattani,

Ofosu-Somuah

et al. 2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Patent Foramen Ovale (PFO) is a common congenital atrial septal defect present in 20%–35% of the general population. Although generally considered a benign anatomic variant, a PFO may facilitate passage of a thrombus from the venous to arterial circulation, thereby resulting in cryptogenic stroke or systemic embolization. A PFO is detected in nearly one half of patients presenting with cryptogenic stroke and often considered the most likely etiology when other causes have been excluded. In this review, we discuss the contemporary role of transcatheter closure of PFO in the treatment of cryptogenic stroke, including devices currently available for commercial use in the United States (Amplatzer PFOTM Occluder and GoreTM Cardioform Septal Occluder) and a novel suture-mediated device (NobleStitchTM EL) under clinical investigation. To provide the best care for cryptogenic stroke patients, practitioners should be familiar with the indications for PFO closure and corresponding treatment options.

show abstract

Section: Introductionmentioning

confidence: 99%